Skip to content
GLP1Pick

Wellorithm vs SnagRx

Both clinics sit in our top 10, so this page exists for readers already comparing them here. It is not written for search and is not submitted for indexing. Every figure below is read from the clinic's own page, with the date.

26 of the 51 clinics we rank are an affiliate partner. Scores come only from our published methodology. At equal displayed scores, active affiliate partners are listed first. What it changes is which clinic a promoted button points at, and every such link carries a PICK badge in the table so you can see it before you click.

WellorithmPick
7.7

Compounded GLP-1 (semaglutide and tirzepatide, injection or oral) AND real brand-name Wegovy, Ozempic, Mounjaro and Zepbound on one menu. $147 for the first month of compounded semaglutide, then $247/mo, with board-certified obesity specialists and 24/7 support.

from $247/mo regular rate for a one-month supply ($147 first month)

Verified 2026-10-06

Visit →Affiliate link

SnagRxSnagRxPick
6.5

Cheap on paper at $69/mo. But it is the same company as Embody trading under a second name, and its "125k+ customers" claim sits beside a Trustpilot profile holding two reviews.

from $69/mo

Verified 2026-09-14

Visit →Affiliate link

 WellorithmSnagRx
Pricefrom $247/mo regular rate for a one-month supply ($147 first month)Their page, read 2026-10-06from $69/moTheir page, read 2026-09-14
Price shapereliable-all-infirst-month-rises
What the price doesn’t sayNothing recorded beyond the figure itself.$69/mo sits under a “Summer Start Discount Applied!” banner against a struck-through $299, so treat it as an entry rate rather than a settled one. Tirzepatide is $119. Worth knowing: this is the same company as Embody (both footers read Modern Metabolic Medicine, Inc.) at the same price under the same promotion, and neither storefront says so.
What it coversNot published. The page does not say what the figure covers.Their page, read 2026-10-06Not published. The page does not say what the figure covers.Their page, read 2026-09-14
Billed on topNot recorded. We have not found a statement either way.Their page, read 2026-10-06Not recorded. We have not found a statement either way.Their page, read 2026-09-14
CommitmentThe page does not state whether a term is required. What happens after the first period: Publishes both figures on its semaglutide card: "first month $147", then "Second month and on. $247" (read 6 October 2026). $247 is the recurring rate shown here; $147 is the first month only..Their page, read 2026-10-06Committed term. What happens after the first period: Claims “GLP-1 with Locked-In Flat Pricing for Life”, i.e. asserts the rate does not rise. A claim on its own page, which we record rather than endorse.Their page, read 2026-09-14
Routescompounded semaglutide, compounded tirzepatide, oral, brand-name Wegovy/Ozempic/Mounjaro/Zepboundcompounded semaglutide, compounded tirzepatide
Score7.76.5

What is on the record

Documented findings, each with its source and date on the clinic’s review page. An FDA warning letter is an allegation by the agency, not a court ruling.

Wellorithm

Nothing documented in what we check.

SnagRx

What one does that the other doesn’t

Wellorithm

Offers oral/sublingual, brand-name where SnagRx does not.

SnagRx

Nothing Wellorithm does not also offer, on the routes we record.

Who each one suits

Every line below is a difference we can measure, with the field or criterion it comes from. Where a side is empty, nothing in what we record favours it. We would rather say that than invent a reason.

Wellorithm

  • The two entry figures are not comparable: SnagRx's rises after the first period.Basis: published price terms (introductory rate)
  • Requires no committed term as far as its page says. But its page does not state one either way.Basis: commitment term not stated on the clinic's page
  • Only one of the two offering: oral/sublingual, brand-name.Basis: published treatments, by drug and route
  • Scores clearly higher on clinical (8.0 vs 5.5).Basis: our published scoring rubric
  • Scores clearly higher on transparency (8.0 vs 5.0).Basis: our published scoring rubric
  • Scores clearly higher on treatment (9.5 vs 7.5).Basis: our published scoring rubric

SnagRx

  • Scores clearly higher on pricing (8.5 vs 5.5).Basis: our published scoring rubric

Full write-ups: Wellorithm · SnagRx